Computational Medicine and Drug Discovery Software Market By Tools 2021 | IndustryARC
  • 1-614-588-8538 (Ext: 101)
  • US Toll Free

Computational medicine and drug discovery software market
Computational Medicine and Drug Discovery Software Market Analysis: By Tools (Software, Databases and Others); By Application (Drug Discovery and Development, Disease Modeling, Medical Imaging and Others) & By Geography - Forecast (2016-2021)
Report Code : HCR 0016
Published: 05 July, 2016   No. of pages: 225

  • Report Description
  • Table of Contents
  • Tables And Figures
  • Customization Options
Computational Medicine and Drug Discovery Software, as the name suggests, is an interdisciplinary subject that goes for creating innovative solutions for important clinical problems to improve human health. There are many clinical applications of computational medicine which help in the process of data collection and development of tools for clinical decision making. Computational Medicine finds its roots in chemistry and quantum mechanics. The foundation of computational medicine is based upon database and constraint-based models. Database is basically repositories of information which is used in constraint-based models to understand protein-ligand interaction. The global market for computational medicine and drug discovery software was estimated to be $5.2 billion in 2015 and is projected to escalate to $7.1 billion by 2021.

Computational Medicine and Drug Discovery Software Market

The computational medicine and drug discovery software market has been extensively studied based on several differentiating parameters to provide a comprehensive overview. The market has been segmented based on following parameters: tools, application and geography. Each of the categories has been further segregated into specific sub-divisions to consider the dynamics associated with this industry. Based on tools, software remained pre-dominant choice in 2015 followed by database. The applications considered in the report include computational physiological medicine, drug discovery and development, medical imaging, disease modeling, predictive analysis of drug targets, cellular simulation and simulation software. A similar strategy was followed to investigate the industry dynamics for computational medicine and drug discovery software specific to eminent countries that constituted the overall regional market including Americas, Europe, Asia-Pacific (APAC) and Rest of the World (RoW).

In 2015, the market share for medical imaging was 38.3% and is projected to grow at a CAGR of 4.2% during the forecast period. The main driving factor for the market are rising bioinformatics in drug discovery, three dimensional drug discovery methodology evolution and increase in late stage drug discovery failure.

Some of the established players in the market include:
  • Compugen Ltd.
  • Certara, L.P.
  • Dassault Systemes
  • Schrödinger LLC
  • Genedata AG.
1. Computational Medicine And Drug Discovery Software Market Overview   
2. Executive Summary   
3. Computational Medicine And Drug Discovery Software Market Landscape   

   3.1. Market Share Analysis   
   3.2. Comparative Analysis   
      3.2.1. Product Benchmarking   
      3.2.2. End User Profiling   
4. Computational Medicine And Drug Discovery Software - Market Forces   
   4.1. Market Drivers   
      4.1.1. The Rise Of Bioinformatics In Drug Discovery   
      4.1.2 . Three Dimensional Drug Discovery Methodology   
      4.1.3. Increase In Late Stage Drug Discovery Failure   
   4.2. Market Challenges   
      4.2.1. Lack Of Skilled Professionals   
      4.2.2. Complexity Associated With Analysis Of Data   
   4.3. Market Constraints   
      4.3.1. Stringent Regulatory Approval For Novel Drugs   
   4.4. Attractiveness Of The Industry   
      4.4.1. Power Of Suppliers   
      4.4.2. Power Of Customers   
      4.4.3. Threat Of New Entrants   
      4.4.4. Threat Of Substitution   
      4.4.5. Degree Of Competition   
5. Computational Medicine And Drug Discovery Software Market – Strategic Analysis   
   5.1. Opportunity Analysis   
      5.1.1. Cloud And Mobile Platforms Provides Investment Opportunities   
      5.1.2. Enterprise Level Computational Softwares Holds Growth Prospects   
   5.2. Value Chain Analysis   
   5.3. Product/Industry Life Cycle Analysis   
   5.4. Suppliers & Distributors   
   5.5. Pricing Analysis   
6. Computational Medicine And Drug Discovery Software Market – By Tools   
   6.1. Introduction   
   6.2. Database   
   6.3. Software   
   6.4. Others   
7. Computational Medicine And Drug Discovery Software Market – By Application   
   7.1. Introduction   
   7.2. Computational Physiological Medicine   
   7.3. Drug Discovery And Development   
   7.4. Medical Imaging   
   7.5. Disease Modeling   
   7.6. Predictive Analysis Of Drug Targets   
   7.7. Cellular Simulation   
   7.8. Simulation Software   
8. Computational Medicine & Drug Discovery Software Market- By Geography   
   8.1. Introduction   
   8.2. Americas   
      8.2.1. U.S.   
      8.2.2. Canada   
      8.2.3. Rest Of Americas   
   8.3. Europe   
      8.3.1. U.K.   
      8.3.2. Germany   
      8.3.3. The Netherlands   
      8.3.4. Norway   
      8.3.5. Italy   
      8.3.6. Rest Of Europe   
   8.4. Apac   
      8.4.1. China   
      8.4.2. Japan   
      8.4.3. Korea   
      8.4.4. Australia   
      8.4.5. Rest Of Apac   
   8.5. Row   
9. Market Entropy   
   9.1. Most Preferred Strategy – Product Expansion   
      9.1.1. Product Expansion   
      9.1.2. Partnerships/Collaborations   
      9.1.3. Other Developments (2011-2015)   
10. Company Profiles   
   10.1. Entelos, Inc.   
   10.2. Genedata Ag   
   10.3. Crown Bioscience Inc.   
   10.4. Biognos Ab   
   10.5. Chemical Computing Group Inc.   
   10.6. Leadscope, Inc.   
   10.7. Nimbus Therapeutics, Inc.   
   10.8. Rhenovia Pharma Limited   
   10.9. Schrödinger, Llc   
   10.1. Compugen Ltd.   
   10.11. Dassault Systemes   
*More than 40 Companies are profiled in this Research Report, Complete List available on Request*
"*Financials would be provided on a best efforts basis for private companies"
11. Appendix   

   11.1. Acronyms   
   11.2. Patents   
   11.3. Research Methodology   

List of Tables:

Table 1. Computational Medicine and Drug Discovery Software Market: Top Companies with Rankings, 2015   
Table 2. Regional Markets and Their Life Cycle Stages   
Table 3. Databases for Genome and Proteome Annotation   
Table 4. Softwares for Genome Annotation   
Table 5. Drug Discovery & Development Process   
Table 6. Global Computational Medicine and Drug Discovery Software Market, by Region, 2014-2020 ($Million)   
Table 7. Americas: Computational Medicine and Drug Discovery Software Market, by Tools, 2014-2020 ($Million)   
Table 8. Americas: Computational Medicine and Drug Discovery Software Market, by Application, 2014-2020 ($Million)   
Table 9. Americas: Computational Medicine and Drug Discovery Software Market, by Country, 2014-2020 ($Million)   
Table 10. Europe: Computational Medicine and Drug Discovery Software Market, by Tools, 2014-2020 ($Million)   
Table 11. Europe: Computational Medicine and Drug Discovery Software Market, by Application, 2014-2020 ($Million)   
Table 12. Europe: Computational Medicine and Drug Discovery Software Market, by Country, 2014-2020 ($Million)   
Table 13. APAC: Computational Medicine and Drug Discovery Software Market, by Tools, 2014-2020 ($Million)   
Table 14. APAC: Computational Medicine and Drug Discovery Software Market, by Application, 2014-2020 ($Million)   
Table 15. APAC: Computational Medicine and Drug Discovery Software Market, by Country, 2014-2020 ($Million)   
Table 16. Computational Medicine and Drug Discovery Software Market: Product Expansion   
Table 17. Computational Medicine and Drug Discovery Software Market: Partnerships/Collaboration   
Table 18. Biognos AB: Products and Applications   
Table 19. Chemical Computing Group Inc: Products and Applications   
Table 20. Compugen Ltd. : Products and Applications   
Table 21. Dassault Systèmes: Computational Medicine and Drug Discovery Software Products and Applications   


List of Figures:

Figure 1. Computational Medicine and Drug Discovery Software, Classification   
Figure 2. Computational Medicine and Drug Discovery Software, by Tools   
Figure 3. Computational Medicine and Drug Discovery Software, by Application   
Figure 4. Computational Medicine and Drug Discovery Software, by Geography   
Figure 5. Global Computational Medicine and Drug Discovery Market, 2014-2020 ($Million)   
Figure 6. Computational Medicine and Drug Discovery Market Share, by Geography, 2014 (%)   
Figure 7. Computational Medicine and Drug Discovery Software Market: Value Chain   
Figure 8. Global Computational Medicine and Drug Discovery Market Revenue, by Region, 2014 & 2020 ($Million)   
Figure 9. Current and Future Focus Parameters   
Figure 10. Global CMDD Database Market Revenue, 2014-2020 ($Million)   
Figure 11. Global CMDD Software Market Revenue, 2014-2020 ($Million)   
Figure 12. Global CMDD Others Market Revenue, 2014-2020 ($Million)   
Figure 13. Global Computational Medicine and Drug Discovery Software Market, by Application, 2014-2020 ($Million)   
Figure 14. Global CMDDS Computational Physiological Medicine Market, 2014-2020 ($Million)   
Figure 15. Global CMDDS Drug Discovery and Development Market, 2014-2020 ($Million)   
Figure 16. NHS Imaging Activities in England, 2014 (Units)    
Figure 17. Global CMDDS Medical Imaging Market, 2014-2020 ($Million)   
Figure 18. Global CMDDS Disease Modeling Market, 2014-2020 ($Million)   
Figure 19. Global CMDDS Predictive Analysis of Drug Target Market, 2014-2020 ($Million)   
Figure 20. Global CMDDS Cellular Simulation Market, 2014-2020 ($Million)   
Figure 21. Global CMDDS Simulation Software Market, 2014-2020 ($Million)   
Figure 22. U.S.: Computational Medicine and Drug Discovery Software Market Revenue, 2014-2020 ($Million)   
Figure 23. Canadian Pharmaceutical Industry: R&D Expenditure, 2007-2013 ($Billion)   
Figure 24. Canada: Computational Medicine and Drug Discovery Software Market Revenue, 2014-2020 ($Million)   
Figure 25. Rest of Americas: Computational Medicine and Drug Discovery Software Market Revenue, 2014-2020 ($Million)   
Figure 26. U.K.: Computational Medicine and Drug Discovery Software Market Revenue, 2014-2020 ($Million)   
Figure 27. Germany: Computational Medicine and Drug Discovery Software Market Revenue, 2014-2020 ($Million)   
Figure 28. The Netherlands: Computational Medicine and Drug Discovery Software Market Revenue, 2014-2020 ($Million)   
Figure 29. Norway: Total Spending on Healthcare as a Percentage of GDP at Market Prices, 1970-2014 (%)   
Figure 30. Norway: Computational Medicine and Drug Discovery Software Market, 2014-2020 ($Million)   
Figure 31. Italy: Total Spending on Healthcare as a Percentage of GDP at Market Prices, 1970-2014 (%)   
Figure 32. Italy: Computational Medicine and Drug Discovery Software Market, 2014-2020 ($Million)   
Figure 33. Rest of Europe Computational Medicine and Drug Discovery Software Market, 2014-2020 ($Million)   
Figure 34. Total Health Expenditure in APAC Countries, 2014 (% of GDP)   
Figure 35. China: Computational Medicine and Drug Discovery Software Market Revenue, 2014-2020 ($Million)   
Figure 36. Japan: Computational Medicine and Drug Discovery Software Market Revenue, 2014-2020 ($Million)   
Figure 37. Korea: Computational Medicine and Drug Discovery Software Market Revenue, 2014-2020 ($Million)   
Figure 38. Australia: Computational Medicine and Drug Discovery Software Market Revenue, 2014-2020 ($Million)   
Figure 39. Rest of APAC: Computational Medicine and Drug Discovery Software Market Revenue, 2014-2020 ($Million)   
Figure 40. Healthcare Spending in Middle East and Africa, 2008-2014 ($Billion)   
Figure 41. Row: Computational Medicine and Drug Discovery Software Market, by Tools, 2014-2020 ($Million)   
Figure 42. Row: Computational Medicine and Drug Discovery Software Market, by Application, 2014-2020 ($Million)   
Figure 43. Total Developments, by Type of Development, 2011-2015   
Figure 44. Financial Performance, 2010-2014, ($Millionn)   
Figure 45. Compugen Ltd. Total Revenue from Sales to Customers, by Region, 2014 (%)   
Figure 46. Dassault Systemes: Financial Performance, 2012-2014, ($Billion)   
Figure 47. Dassault Systemes: Total Revenue, by Region, 2014, (%)   


Please select Licence
Single User Licence:
US $4250
Corporate User Licence:
US $6250
Related Reports